Compare Mutual Funds
Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 2/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 9 Months | 13 Years 4 Months | ||
Fund AUM | ₹6801 Cr | ₹8306 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.04% | 0.93% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 43 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.98% | 99.7% | ||
Debt % | - | - | ||
P/E | 32.15 | 35.73 | ||
P/B | 3.94 | 5.7 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -1.66% | -1.69% | ||
3-Month Return | -6.54% | -2.35% | ||
6-Month Return | -9.11% | -4.69% | ||
1-Year Return | 3.3% | 3.56% | ||
3-Year Return | 28.11% | 24.22% | ||
5-Year Return | 18.42% | 16.64% |
Sharpe | 1.3 | 1.17 | ||
Alpha | 2.27 | 0.22 | ||
Beta | 0.94 | 0.9 | ||
Standard Deviation | 15.86 | 15.21 | ||
Information Ratio | 0.44 | -0.47 |
Description | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dharmesh Kakkad, Sharmila D’mello | Sailesh Raj Bhan, Kinjal Desai, Divya Sharma, Lokesh Maru |

